Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan-R Targan

Showing results (31-40 of 181) with videos related to

Pageof 19
Sort By:
Inflammatory Bowel Diseases|August 30, 2014
IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretionRivkah Gonsky, Richard L Deem, Carol J Landers, et al.
Inflammatory Bowel Diseases|October 29, 2005
State of the art: IBD therapy and clinical trials in IBDKim L Isaacs, James D Lewis, William J Sandborn, et al.
The American Journal of Gastroenterology|February 26, 2009
Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's diseaseDaniel C Baumgart, James N Lowder, Stephan R Targan, et al.
The American Journal of Gastroenterology|June 18, 2003
Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprineMarla C Dubinsky, Edward J Feldman, Maria T Abreu, et al.
Inflammatory Bowel Diseases|December 17, 2021
Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem CellsHannah Q Estrada, Shachi Patel, Shervin Rabizadeh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn's diseaseMasayuki Saruta, Qi T Yu, Armine Avanesyan, et al.
Inflammatory Bowel Diseases|October 12, 2004
The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel diseaseRobin Matuk, Jonathan Crawford, Maria T Abreu, et al.
Journal of Clinical Immunology|March 30, 2010
TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targetsStephanie C Heidemann, Valerie Chavez, Carol J Landers, et al.
Inflammatory Bowel Diseases|January 8, 2013
HMPL-004 (Andrographis paniculata extract) prevents development of murine colitis by inhibiting T-cell proliferation and TH1/TH17 responsesKathrin S Michelsen, Michelle H Wong, Brian Ko, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2006
Case report: evidence for transplacental transfer of maternally administered infliximab to the newbornEric A Vasiliauskas, Joseph A Church, Neil Silverman, et al.
Pageof 19

Showing results (31-40 of 181) with videos related to

Sort By:
Pageof 19
Inflammatory Bowel Diseases|August 30, 2014
IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretionRivkah Gonsky, Richard L Deem, Carol J Landers, et al.
Inflammatory Bowel Diseases|October 29, 2005
State of the art: IBD therapy and clinical trials in IBDKim L Isaacs, James D Lewis, William J Sandborn, et al.
The American Journal of Gastroenterology|February 26, 2009
Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's diseaseDaniel C Baumgart, James N Lowder, Stephan R Targan, et al.
The American Journal of Gastroenterology|June 18, 2003
Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprineMarla C Dubinsky, Edward J Feldman, Maria T Abreu, et al.
Inflammatory Bowel Diseases|December 17, 2021
Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem CellsHannah Q Estrada, Shachi Patel, Shervin Rabizadeh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn's diseaseMasayuki Saruta, Qi T Yu, Armine Avanesyan, et al.
Inflammatory Bowel Diseases|October 12, 2004
The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel diseaseRobin Matuk, Jonathan Crawford, Maria T Abreu, et al.
Journal of Clinical Immunology|March 30, 2010
TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targetsStephanie C Heidemann, Valerie Chavez, Carol J Landers, et al.
Inflammatory Bowel Diseases|January 8, 2013
HMPL-004 (Andrographis paniculata extract) prevents development of murine colitis by inhibiting T-cell proliferation and TH1/TH17 responsesKathrin S Michelsen, Michelle H Wong, Brian Ko, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2006
Case report: evidence for transplacental transfer of maternally administered infliximab to the newbornEric A Vasiliauskas, Joseph A Church, Neil Silverman, et al.
Pageof 19